CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Class A and Class B common stock	Additional paid-in capital	Accumulated other comprehensive income (loss)	Accumulated deficit
Beginning balance at Dec. 31, 2021	$ 2,175,957	$ 175	$ 7,874,038	$ (47,739)	$ (5,650,517)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options		2	12,365
Equity-based compensation			128,509
Foreign currency translation adjustments, net of tax	(1,959)			(1,959)
Actuarial (loss) gain on defined severance benefits, net of tax	38,007			38,007
Net income (loss)	(284,785)				(284,785)
Ending balance at Jun. 30, 2022	2,068,096	$ 177	8,014,912	(11,691)	(5,935,302)
Beginning balance (in shares) at Dec. 31, 2021		1,754,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common units, equity-based compensation plan (in shares)		6,178
Issuance of common stock upon settlement of restricted stock units (in shares)		4,736
Ending balance (in shares) at Jun. 30, 2022		1,765,117
Beginning balance at Mar. 31, 2022	2,037,261	$ 176	7,937,813	(40,917)	(5,859,811)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options		1	4,183
Equity-based compensation			72,916
Foreign currency translation adjustments, net of tax	(4,970)			(4,970)
Actuarial (loss) gain on defined severance benefits, net of tax	34,196			34,196
Net income (loss)	(75,491)				(75,491)
Ending balance at Jun. 30, 2022	2,068,096	$ 177	8,014,912	(11,691)	(5,935,302)
Beginning balance (in shares) at Mar. 31, 2022		1,761,058
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common units, equity-based compensation plan (in shares)		2,031
Issuance of common stock upon settlement of restricted stock units (in shares)		2,028
Ending balance (in shares) at Jun. 30, 2022		1,765,117
Beginning balance at Dec. 31, 2022	2,413,913	$ 177	8,154,076	2,219	(5,742,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options			5,721
Issuance of common stock upon settlement of restricted stock units		1
Equity-based compensation			156,303
Foreign currency translation adjustments, net of tax	(27,680)			(27,680)
Actuarial (loss) gain on defined severance benefits, net of tax	(8,828)			(8,828)
Net income (loss)	236,047				236,047
Ending balance at Jun. 30, 2023	2,775,477	$ 178	8,316,100	(34,289)	(5,506,512)
Beginning balance (in shares) at Dec. 31, 2022		1,772,607
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common units, equity-based compensation plan (in shares)		2,597
Issuance of common stock upon settlement of restricted stock units (in shares)		6,065
Ending balance (in shares) at Jun. 30, 2023		1,781,269
Beginning balance at Mar. 31, 2023	2,560,030	$ 178	8,227,469	(15,913)	(5,651,704)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options			2,227
Equity-based compensation			86,404
Foreign currency translation adjustments, net of tax	(8,692)			(8,692)
Actuarial (loss) gain on defined severance benefits, net of tax	(9,684)			(9,684)
Net income (loss)	145,192				145,192
Ending balance at Jun. 30, 2023	$ 2,775,477	$ 178	$ 8,316,100	$ (34,289)	$ (5,506,512)
Beginning balance (in shares) at Mar. 31, 2023		1,777,291
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common units, equity-based compensation plan (in shares)		1,009
Issuance of common stock upon settlement of restricted stock units (in shares)		2,969
Ending balance (in shares) at Jun. 30, 2023		1,781,269